Cargando…
Bayesian optimization with evolutionary and structure-based regularization for directed protein evolution
BACKGROUND: Directed evolution (DE) is a technique for protein engineering that involves iterative rounds of mutagenesis and screening to search for sequences that optimize a given property, such as binding affinity to a specified target. Unfortunately, the underlying optimization problem is under-d...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246133/ https://www.ncbi.nlm.nih.gov/pubmed/34210336 http://dx.doi.org/10.1186/s13015-021-00195-4 |
_version_ | 1783716248943591424 |
---|---|
author | Frisby, Trevor S. Langmead, Christopher James |
author_facet | Frisby, Trevor S. Langmead, Christopher James |
author_sort | Frisby, Trevor S. |
collection | PubMed |
description | BACKGROUND: Directed evolution (DE) is a technique for protein engineering that involves iterative rounds of mutagenesis and screening to search for sequences that optimize a given property, such as binding affinity to a specified target. Unfortunately, the underlying optimization problem is under-determined, and so mutations introduced to improve the specified property may come at the expense of unmeasured, but nevertheless important properties (ex. solubility, thermostability, etc). We address this issue by formulating DE as a regularized Bayesian optimization problem where the regularization term reflects evolutionary or structure-based constraints. RESULTS: We applied our approach to DE to three representative proteins, GB1, BRCA1, and SARS-CoV-2 Spike, and evaluated both evolutionary and structure-based regularization terms. The results of these experiments demonstrate that: (i) structure-based regularization usually leads to better designs (and never hurts), compared to the unregularized setting; (ii) evolutionary-based regularization tends to be least effective; and (iii) regularization leads to better designs because it effectively focuses the search in certain areas of sequence space, making better use of the experimental budget. Additionally, like previous work in Machine learning assisted DE, we find that our approach significantly reduces the experimental burden of DE, relative to model-free methods. CONCLUSION: Introducing regularization into a Bayesian ML-assisted DE framework alters the exploratory patterns of the underlying optimization routine, and can shift variant selections towards those with a range of targeted and desirable properties. In particular, we find that structure-based regularization often improves variant selection compared to unregularized approaches, and never hurts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13015-021-00195-4. |
format | Online Article Text |
id | pubmed-8246133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82461332021-07-01 Bayesian optimization with evolutionary and structure-based regularization for directed protein evolution Frisby, Trevor S. Langmead, Christopher James Algorithms Mol Biol Research BACKGROUND: Directed evolution (DE) is a technique for protein engineering that involves iterative rounds of mutagenesis and screening to search for sequences that optimize a given property, such as binding affinity to a specified target. Unfortunately, the underlying optimization problem is under-determined, and so mutations introduced to improve the specified property may come at the expense of unmeasured, but nevertheless important properties (ex. solubility, thermostability, etc). We address this issue by formulating DE as a regularized Bayesian optimization problem where the regularization term reflects evolutionary or structure-based constraints. RESULTS: We applied our approach to DE to three representative proteins, GB1, BRCA1, and SARS-CoV-2 Spike, and evaluated both evolutionary and structure-based regularization terms. The results of these experiments demonstrate that: (i) structure-based regularization usually leads to better designs (and never hurts), compared to the unregularized setting; (ii) evolutionary-based regularization tends to be least effective; and (iii) regularization leads to better designs because it effectively focuses the search in certain areas of sequence space, making better use of the experimental budget. Additionally, like previous work in Machine learning assisted DE, we find that our approach significantly reduces the experimental burden of DE, relative to model-free methods. CONCLUSION: Introducing regularization into a Bayesian ML-assisted DE framework alters the exploratory patterns of the underlying optimization routine, and can shift variant selections towards those with a range of targeted and desirable properties. In particular, we find that structure-based regularization often improves variant selection compared to unregularized approaches, and never hurts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13015-021-00195-4. BioMed Central 2021-07-01 /pmc/articles/PMC8246133/ /pubmed/34210336 http://dx.doi.org/10.1186/s13015-021-00195-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Frisby, Trevor S. Langmead, Christopher James Bayesian optimization with evolutionary and structure-based regularization for directed protein evolution |
title | Bayesian optimization with evolutionary and structure-based regularization for directed protein evolution |
title_full | Bayesian optimization with evolutionary and structure-based regularization for directed protein evolution |
title_fullStr | Bayesian optimization with evolutionary and structure-based regularization for directed protein evolution |
title_full_unstemmed | Bayesian optimization with evolutionary and structure-based regularization for directed protein evolution |
title_short | Bayesian optimization with evolutionary and structure-based regularization for directed protein evolution |
title_sort | bayesian optimization with evolutionary and structure-based regularization for directed protein evolution |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246133/ https://www.ncbi.nlm.nih.gov/pubmed/34210336 http://dx.doi.org/10.1186/s13015-021-00195-4 |
work_keys_str_mv | AT frisbytrevors bayesianoptimizationwithevolutionaryandstructurebasedregularizationfordirectedproteinevolution AT langmeadchristopherjames bayesianoptimizationwithevolutionaryandstructurebasedregularizationfordirectedproteinevolution |